Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) (NCT05488431)
🩺 Plain-English Summary (8th-Grade Level)
This is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, immune activation, cardiometabolic indices, and non-calcified plaque (NCP) in the coronary arteries (assessed by coronary CT angiography, CCTA). This trial will be enrolled at UCSF and UCLA. Collaborators at Massachusetts General Hospital (MGH) will serve as the core facility for imaging.
Who can join: Review the eligibility criteria below.
Location: UCLA Center for Clinical AIDS Research and Education (CARE) — Los Angeles, California
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- UCLA Center for Clinical AIDS Research and Education (CARE) — Los Angeles, California
- San Francisco General Hospital — San Francisco, California
- UT Health Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (628) 206-8037
Email: marta.levkova@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dyslipidemias
- Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity — Storrs, Connecticut
- Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction — Toronto, Ontario
- Lipid Testing After Myocardial Infarction at the Montreal Heart Institute — Montreal, Quebec
- Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels — Philadelphia, Pennsylvania
- Group Medical Visits for Patients With Dyslipidemia — Dieppe, New Brunswick
Explore by condition: All Dyslipidemias clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.